Cargando…

Potential benefits of precise corticosteroid therapy for critical COVID-19

This study was aimed to explore the precise dose of corticosteroid therapy in critical COVID-19. A total of forty-five critical COVID-19 patients were enrolled. The process of critical COVID-19 was divided into alveolitis and fibrosis stages. Most nonsurvivors died in fibrosis phase. Nonsurvivors ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qingquan, Yang, Qiongxiu, Fang, Yingying, Chen, Gongping, Lv, Xiaoting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600764/ https://www.ncbi.nlm.nih.gov/pubmed/34801741 http://dx.doi.org/10.1016/j.resp.2021.103813

Ejemplares similares

Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
por: Zhou, Wei, et al.
Publicado: (2020)

Adjuvant corticosteroid therapy for critically ill patients with COVID-19
por: Lu, Xiaofan, et al.
Publicado: (2020)

Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study
por: Li, Yiming, et al.
Publicado: (2020)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
por: Gopalaswamy, Radha, et al.
Publicado: (2021)

Trypsin may induce cytokine storm in M1 macrophages, resulting in critical coronavirus disease
por: Chen, Hongyu, et al.
Publicado: (2022)

Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype
por: Chen, Hui, et al.
Publicado: (2021)

Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2021)

COVID-19 in posttransplant patients—report of 2 cases
por: Huang, Jiaofeng, et al.
Publicado: (2020)

Corticosteroids in severe COVID-19: a critical view of the evidence
por: De Backer, Daniel, et al.
Publicado: (2020)

Low-to-Moderate Dosage and Short-Term Use of Corticosteroids Benefit Patients With Severe COVID-19 Infections
por: Yang, Liuqing, et al.
Publicado: (2022)

Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit()
por: González-Castro, A., et al.
Publicado: (2022)

Survival Benefit of Corticosteroid Replacement in Critically Ill Patients: One Treatment Effect or Two?
por: Laies, Slavita M, et al.
Publicado: (2021)

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
por: Furci, Fabiana, et al.
Publicado: (2021)

Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or Corticosteroids
por: Lam, Carson, et al.
Publicado: (2021)

Pros and cons of corticosteroid therapy for COVID-19 patients
por: Mattos-Silva, Paula, et al.
Publicado: (2020)

Corticosteroids for COVID-19: the search for an optimum duration of therapy
por: Mishra, Gyanshankar P, et al.
Publicado: (2021)

Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients
por: Mandadi, Subhadra, et al.
Publicado: (2022)

Corticosteroids for COVID-19
por: Annane, Djillali
Publicado: (2021)

CJEM journal club: corticosteroids use for critically ill COVID-19 patients
por: Li, Siying S., et al.
Publicado: (2021)

The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients
por: Ritter, Lindsay A., et al.
Publicado: (2021)

Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
por: An, Tai Joon, et al.
Publicado: (2022)

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020)

Caution against corticosteroid-based COVID-19 treatment
por: Tang, Chong, et al.
Publicado: (2020)

Point: Antenatal corticosteroid treatment in the late preterm period—Are the benefits worth the potential risks?
por: Kajantie, Eero
Publicado: (2022)

Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection
por: Mehrabi, Zeinab, et al.
Publicado: (2021)

Loss of an eye to mucormycosis following corticosteroid therapy for COVID-19
por: Rodrigues, Mariana Gonçalves, et al.
Publicado: (2021)

Do Systemic Corticosteroids Reduce Mortality in Critically Ill Adult Patients With COVID-19?
por: Yoo, Michael J., et al.
Publicado: (2021)

Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19
por: Scialò, Filippo, et al.
Publicado: (2022)

THE BENEFITS OF CORTICOSTEROIDS IN COVID-19 WITH ORGANIZING PNEUMONIA-LIKE PATTERN: A CLINICAL REPORT OF SUCCESSFUL TREATMENT
por: ARGEL, MARIANA, et al.
Publicado: (2021)

Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study
por: Li, Yichen, et al.
Publicado: (2021)

Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series
por: Yang, Stephen Su, et al.
Publicado: (2020)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Corticosteroids for COVID-19: worth it or not?
por: Akter, Fariya, et al.
Publicado: (2021)

COVID-19–related Acute Respiratory Distress Syndrome Subphenotypes and Differential Response to Corticosteroids: Time for More Precision?
por: Reddy, Kiran, et al.
Publicado: (2021)

The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
por: Cai, Jingjing, et al.
Publicado: (2021)

Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
por: Miao, Yi, et al.
Publicado: (2020)

PRCTC: a machine learning model for prediction of response to corticosteroid therapy in COVID-19 patients
por: Gao, Yue, et al.
Publicado: (2022)

Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients
por: Awasthi, Samir, et al.
Publicado: (2021)

Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease
por: Liaquat, Hammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gnh3b50679mcia52rhlr0k3n5g